+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Lymphoma Drugs Market Research Reports

Hodgkin's Lymphoma- Pipeline Insight, 2025 - Product Thumbnail Image

Hodgkin's Lymphoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Peripheral T-Cell Lymphomas (PTCL) - Pipeline Insight, 2025 - Product Thumbnail Image

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Malt Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Malt Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Natural Killer T Cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Natural Killer T Cell Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
CAR T-Cell Therapy For Non-Hodgkin's Lymphoma- - Pipeline Insight, 2025 - Product Thumbnail Image

CAR T-Cell Therapy For Non-Hodgkin's Lymphoma- - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Relapsed And Refractory CD5-Expressing T Cell Lymphomas - Pipeline Insight, 2025 - Product Thumbnail Image

Relapsed And Refractory CD5-Expressing T Cell Lymphomas - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
T Cell Lymphoma -Pipeline Insight, 2025 - Product Thumbnail Image

T Cell Lymphoma -Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 250 Pages
  • Global
From
Lymphatic Malformations- - Pipeline Insight, 2025 - Product Thumbnail Image

Lymphatic Malformations- - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Mantle Cell Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Mantle Cell Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • May 2025
  • 185 Pages
  • Global
From
T-Cell Lymphoma Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Thumbnail Image

T-Cell Lymphoma Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • April 2025
  • 182 Pages
  • Global
From
Diffuse Large B-cell Lymphoma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Diffuse Large B-cell Lymphoma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • March 2025
  • 183 Pages
  • Global
From
Diffuse Large B-cell Lymphoma (DLBCL) Therapeutics Market 2025-2029 - Product Thumbnail Image

Diffuse Large B-cell Lymphoma (DLBCL) Therapeutics Market 2025-2029

  • Report
  • May 2025
  • 220 Pages
  • Global
From
Non-hodgkin Lymphoma (NHL) Therapeutics Market 2024-2028 - Product Thumbnail Image

Non-hodgkin Lymphoma (NHL) Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 190 Pages
  • Global
From
T-cell Lymphoma Market Size, Share & Trends Analysis Report By Type, By Therapy (Chemotherapy, Radiotherapy, Immunotherapy, Stem Cell Transplantation, and Others), By Regional Outlook and Forecast, 2024 - 2031 - Product Thumbnail Image

T-cell Lymphoma Market Size, Share & Trends Analysis Report By Type, By Therapy (Chemotherapy, Radiotherapy, Immunotherapy, Stem Cell Transplantation, and Others), By Regional Outlook and Forecast, 2024 - 2031

  • Report
  • August 2024
  • 208 Pages
  • Global
From
B-Cell Non-Hodgkin's Lymphoma: Epidemiology Forecast to 2033 - Product Thumbnail Image

B-Cell Non-Hodgkin's Lymphoma: Epidemiology Forecast to 2033

  • Report
  • March 2025
  • 55 Pages
  • Global
From
T-Cell Lymphoma Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Thumbnail Image

T-Cell Lymphoma Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • March 2025
  • 130 Pages
  • Global
From
North America T-cell Lymphoma Market Size, Share & Trends Analysis Report By Type, By Therapy (Chemotherapy, Radiotherapy, Immunotherapy, Stem Cell Transplantation, and Others), By Country and Growth Forecast, 2024 - 2031 - Product Thumbnail Image

North America T-cell Lymphoma Market Size, Share & Trends Analysis Report By Type, By Therapy (Chemotherapy, Radiotherapy, Immunotherapy, Stem Cell Transplantation, and Others), By Country and Growth Forecast, 2024 - 2031

  • Report
  • August 2024
  • 82 Pages
  • North America
From
LAMEA T-cell Lymphoma Market Size, Share & Trends Analysis Report By Type, By Therapy (Chemotherapy, Radiotherapy, Immunotherapy, Stem Cell Transplantation, and Others), By Country and Growth Forecast, 2024 - 2031 - Product Thumbnail Image

LAMEA T-cell Lymphoma Market Size, Share & Trends Analysis Report By Type, By Therapy (Chemotherapy, Radiotherapy, Immunotherapy, Stem Cell Transplantation, and Others), By Country and Growth Forecast, 2024 - 2031

  • Report
  • August 2024
  • 93 Pages
  • Middle East, Africa
From
Europe T-cell Lymphoma Market Size, Share & Trends Analysis Report By Type, By Therapy (Chemotherapy, Radiotherapy, Immunotherapy, Stem Cell Transplantation, and Others), By Country and Growth Forecast, 2024 - 2031 - Product Thumbnail Image

Europe T-cell Lymphoma Market Size, Share & Trends Analysis Report By Type, By Therapy (Chemotherapy, Radiotherapy, Immunotherapy, Stem Cell Transplantation, and Others), By Country and Growth Forecast, 2024 - 2031

  • Report
  • August 2024
  • 91 Pages
  • Europe
From
Asia Pacific T-cell Lymphoma Market Size, Share & Trends Analysis Report By Type, By Therapy (Chemotherapy, Radiotherapy, Immunotherapy, Stem Cell Transplantation, and Others), By Country and Growth Forecast, 2024 - 2031 - Product Thumbnail Image

Asia Pacific T-cell Lymphoma Market Size, Share & Trends Analysis Report By Type, By Therapy (Chemotherapy, Radiotherapy, Immunotherapy, Stem Cell Transplantation, and Others), By Country and Growth Forecast, 2024 - 2031

  • Report
  • August 2024
  • 94 Pages
  • Asia Pacific
From
Loading Indicator

The Lymphoma Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat lymphoma, a type of cancer that affects the lymphatic system. These drugs are used to reduce the size of tumors, reduce symptoms, and improve the quality of life for those affected by the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy. Chemotherapy is the most common form of treatment for lymphoma, and involves the use of drugs to kill cancer cells. Targeted therapy is a newer form of treatment that uses drugs to target specific cancer cells, while immunotherapy uses drugs to stimulate the body's own immune system to fight the cancer. The Lymphoma Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more